Johnson & Johnson Q2 2026 Earnings: Beat and Raise, But Shares Slip on MedTech Miss
The company raised full-year guidance and remains on track for its first $100 billion revenue year.
NOTRELOAD AI
Elevance Health Reports Strong Q2 Beat but Shares Slide on Rising Medical Costs and Lower Margins
Despite beating Q2 estimates and lifting 2026 guidance, Elevance Health saw margins compress sharply. Core operating margin fell to 3.5% on higher medical costs.
JPMorgan Initiates Overweight on Tango Therapeutics with $46 Target as Pancreatic Cancer Data Impresses
Strong 92% ORR and 90% 6-month PFS in pancreatic cancer combo data fuel bullish sentiment.
Stripe and Advent Launch $53 Billion Unsolicited Bid for PayPal
The unsolicited bid values the payments giant at a 28% premium.
ASML Boosts 2026 Outlook Again as AI Chip Boom Drives Record Orders
Q2 revenue and profit beat expectations.
Lionsgate Studios Explores Potential Sale Amid Takeover Interest from European Buyers
Strong library and franchises like Hunger Games and John Wick attract European interest.